NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma

Shangwen Liu1, Xin Ma, Qing Ai

  • 1Department of Urology, Chinese People's Liberation Army General Hospital, Beijing, P.R. China.

Urologic Oncology
|October 14, 2011
PubMed
Abstract

Insights

NOTCH1 receptor expression is elevated in clear cell renal cell carcinoma (CCRCC). This study shows NOTCH1 regulates PTEN and PI3K/AKT pathway activity, offering potential therapeutic targets for CCRCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • NOTCH1 signaling is crucial for cell fate and development.
  • The role of NOTCH1 in clear cell renal cell carcinoma (CCRCC) pathogenesis remains unclear.
  • Investigating NOTCH1's interaction with the PTEN/PI3K/AKT pathway is essential.

Purpose of the Study:

  • To examine NOTCH1 expression patterns in CCRCC tissues.
  • To elucidate the interaction between NOTCH1 and the PTEN/PI3K/AKT pathway in vitro.
  • To assess the functional impact of NOTCH1 signaling on CCRCC cell behavior.

Main Methods:

  • Western blotting and qRT-PCR were used to analyze NOTCH1, HES1, PTEN, and AKT expression in CCRCC tissues and cell lines.
  • NOTCH1 knockdown and overexpression were performed using siRNA and plasmid transfection.
  • Cell proliferation, apoptosis, invasion, and migration were evaluated using MTS assays, flow cytometry, and transwell assays.

Main Results:

  • NOTCH1 expression was significantly increased in CCRCC tissues compared to non-neoplastic samples.
  • NOTCH1 signaling was constitutively active in CCRCC cell lines.
  • Blocking NOTCH1 attenuated proliferation, invasion, and migration, while up-regulating PTEN and decreasing AKT phosphorylation.

Conclusions:

  • NOTCH1 receptor is upregulated in CCRCC.
  • NOTCH1 regulates PTEN expression and PI3K/AKT pathway activity via HES1.
  • These findings suggest NOTCH1 as a potential therapeutic target for CCRCC.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...